Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,214.1
19.4 (0.61%)

 

  • STI Straits Times Index
    3,214.1
    19.4 (0.61%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.2
    3.8 (0.24%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,687.8
    693.6 (2.57%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,967.7
    52.0 (1.78%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    24,023.1
    598.3 (2.55%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,197.3
    57.9 (0.94%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,170.2
    32.9 (1.54%)
    Index delayed 20 minutes
  • XAO XAO
    6,844.6
    33.8 (0.50%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 969.2M
  • Value: 1,355.0M
  • Rise: 174
  • Fall: 117
  • Unch: 535

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.186+0.007
Golden Agri-Res0.220-
YZJ Shipbldg SGD1.130+0.040
Artivision Tech0.003-0.001
Ascendas Reit2.910-0.080
CapitaMall Trust2.420-0.040
Genting Sing0.930-0.005
ThaiBev0.920+0.010
Mapletree Com Tr2.260-0.020
SingTel3.390-

World Indices

World Indices
Name Last Change
Nasdaq 8,734.9 +17.6
HSI 27,687.8 +693.6
HSCEI 10,838.1 +223.3
Jakarta 6,197.3 +57.9
Nikkei 225 24,023.1 +598.3
SSE Comp 2,967.7 +52.0
Shanghai A 3,109.7 +54.5
Shanghai B 245.9 +3.2
PSE Comp 0.0
KOSPI 2,170.2 +32.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

RAPT THERAPEUTICS INC RAPT THERAPEUTICS INC
Updated on 13 Dec 2019 (End of trading day)
Last (USD): 23.720 Change: +2.040 High: 23.940 Remarks: -
Change (%): +9.41 Low: 21.600
Open 21.650 Yesterday's Close 21.68
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 47,978 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.69865 Trailing EPS (USD) e -1.69865 NAV (USD) b -5.8645
PE a - Trailing PE f - Price / NAV b -4.0447
Dividend (USD) d - Cash In Hand (USD) g 2.2702 Issued & Paid-up Shares c 21,279,900
Dividend Yield (%) d - Price / Cash In Hand g 10.448 Treasury Shares h -
Beta - 75 Daysi 8.956 R-Squared - 75 Days(%)i 6.88 Market Cap (M) 504.759
Beta - 500 Daysi 8.280 R-Squared - 500 Days (%)i 7.48 Enterprise Value (M) 631.939
Piotroski F Score 2 Exchange Code RAPT Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 36.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 26 Jul 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference RAPT THERAPEUTICS INC NASDAQ 504.759 - - -4.0447 -
Industry Biotechnology NASDAQ 2,347.273 404.218 168.111 5.8754 0.745
Local Peer AMGEN INC NASDAQ 140,667.120 16.758 17.437 12.8734 2.363
Local Peer GILEAD SCIENCES INC NASDAQ 83,208.916 15.254 30.898 4.0385 3.513
Local Peer VERTEX PHARMACEUTICAL NASDAQ 56,310.707 26.861 26.267 10.7189 -
Local Peer BIOGEN INC NASDAQ 53,560.599 12.089 9.927 3.8269 -
Local Peer ILLUMINA INC NASDAQ 47,733.840 57.789 49.058 10.7533 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 41,329.399 16.908 19.275 3.9345 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,434.952 314.883 16.619 2.3569 -
Local Peer INCYTE CORPORATION NASDAQ 19,710.979 180.021 48.673 8.1365 -
Local Peer SEATTLE GENETICS INC NASDAQ 19,515.724 - - 10.9663 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 14,400.536 - - 4.6840 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 13,528.983 - 43.591 4.8948 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 13,126.833 - - 8.1681 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), REPLIGEN CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), XENCOR INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), NEXTCURE INC (NASDAQ), ALECTOR INC (NASDAQ), VIELA BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INTREXON CORP (NASDAQ), CORTEXYME INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), OMEROS CORP (NASDAQ), DERMIRA INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RETROPHIN INC (NASDAQ), ARDELYX INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), IMMUNOGEN INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AGENUS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), RECRO PHARMA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), MEDICINOVA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), GERON CORP (NASDAQ), KAMADA (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), NANTKWEST INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), CABALETTA BIO INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMV INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), SESEN BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), NOVAVAX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), INFLARX N V (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), EQUILLIUM INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), VACCINEX INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), COHBAR INC (NASDAQ), TREVENA INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SAVARA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), CURIS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), RESTORBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), BIOCARDIA INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SOLIGENIX INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), SENESTECH INC (NASDAQ), VAXART INC (NASDAQ), PRECIPIO INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), TOCAGEN INC (NASDAQ), OCUGEN INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), TROVAGENE INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ)
Global Peer CSL ASX 126,230.603 47.050 47.050 16.8686 0.954
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 25,905.566 81.979 24.188 5.4561 0.732
Global Peer SINO BIOPHARM HKEx 129,562.909 12.092 12.549 3.8585 0.710
Global Peer WUXI BIO HKEx 121,568.327 162.763 127.243 12.5139 -
Global Peer BEIGENE HKEx 85,666.018 - - 8.5473 -
Global Peer GENSCRIPT BIO HKEx 34,877.863 209.745 - 9.8354 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer 3SBIO HKEx 27,025.281 17.865 21.745 2.6637 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,682.899 42.790 623.930 2.5922 -
Other Global Peers HAOHAI BIOTEC (HKEx), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), VIVA BIOTECH (HKEx), POLYNOVO LIMITED (ASX), AVITA MEDICAL LTD (ASX), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), MESOBLAST LTD (ASX), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), LEE'S PHARM (HKEx), PFENEX INC (NYSE American), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), NEXT SCIENCE LTD (ASX), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), BBI LIFE SCI (HKEx), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), UNI-BIO GROUP (HKEx), NANOVIRICIDES INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), ENZO BIOCHEM INC (NYSE), RESAPP HEALTH LIMITED (ASX), PYC THERAPEUTICS LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), CEL-SCI CORP (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), IMMUTEP LTD (ASX), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), ISORAY INC (NYSE American), BIOSINO BIO-TEC (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), BIONOMICS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), NOVITA HEALTHCARE LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENT PACIFIC (HKEx), MEMPHASYS LTD (ASX), ORAGENICS INC (NYSE American), BIOTRON (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), IBIO INC (NYSE American), RHINOMED LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), EXTRAWELL PHAR (HKEx), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), ANTEOTECH LIMITED (ASX), CELLMID LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), REGENEUS LTD (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), Suntar Eco-City^ (SGX), ALTERITY THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), ADALTA LTD (ASX), CCP TECHNOLOGIES LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), MEGASUN (Bursa), HAO WEN HLDGS (HKEx), MGRC (Bursa), SIENNA CANCER DIAGNOSTICS LTD (ASX), MEDIBIO LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AIM IMMUNOTECH INC (NYSE American), QT Vascular (SGX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.880
-3.58 %
10 Days --2.190
-8.45 %
20 Days -+4.040
+20.53 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 11.850 - 42.000 Change From 1 Year Low +11.870 % Change From 1 Year Low (%) +100.17
Change From 1 Year High -18.280 % Change From 1 Year High (%) -43.52
2 Years Range 11.850 - 42.000 Change From 2 Years Low +11.870 % Change From 2 Years Low (%) +100.17
Change From 2 Years High -18.280 % Change From 2 Years High (%) -43.52
5 Years Range 11.850 - 42.000 Change From 5 Years Low +11.870 % Change From 5 Years Low (%) +100.17
Change From 5 Years High -18.280 % Change From 5 Years High (%) -43.52
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
13 Dec 2019 21.650 23.940 21.600 23.720 47,978 -
12 Dec 2019 22.880 24.607 21.000 21.680 100,202 -
11 Dec 2019 24.760 25.500 22.870 22.890 54,465 -
10 Dec 2019 25.890 26.236 24.260 24.730 60,458 -
09 Dec 2019 24.640 26.600 24.140 25.130 51,024 -
06 Dec 2019 26.490 27.735 24.162 24.600 75,003 -
05 Dec 2019 27.000 28.880 26.000 26.200 72,461 -
04 Dec 2019 27.990 31.464 27.000 27.530 205,139 -
03 Dec 2019 22.700 25.261 22.000 24.950 68,522 -
02 Dec 2019 25.570 27.790 21.192 21.730 69,371 -
29 Nov 2019 26.600 26.698 25.500 25.910 12,575 -
27 Nov 2019 27.410 27.950 25.286 26.669 40,579 -
26 Nov 2019 30.200 30.250 24.380 27.260 164,227 -
25 Nov 2019 21.200 30.760 21.017 29.470 337,572 -
22 Nov 2019 20.770 21.056 19.785 20.490 19,240 -
21 Nov 2019 21.500 21.500 19.690 20.700 21,089 -
20 Nov 2019 17.790 21.860 17.720 21.240 79,652 -
19 Nov 2019 17.420 18.300 15.250 17.790 29,556 -
18 Nov 2019 19.210 19.900 16.490 17.790 70,202 -
15 Nov 2019 21.120 25.340 18.974 19.680 58,109 -
14 Nov 2019 20.616 22.448 19.250 21.180 36,899 -
13 Nov 2019 22.150 23.390 19.500 20.380 63,124 -
Summary
Current 2 Weeks
(02 Dec 2019 to 13 Dec 2019)		 25.570 31.464 21.000 23.720 804,623 -
Previous 2 Weeks
(15 Nov 2019 to 29 Nov 2019)		 21.120 31.464 18.974 25.910 832,801 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.